Commentary: Identifying individualized predictions of response in ADHD pharmacotherapy - a commentary on Rodrigues et al. (2020)
Carregando...
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
BLOCH, Michael H.
Citação
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, v.62, n.6, p.701-703, 2021
Resumo
In this issue, Rodrigues et al. (2020) present a systematic review with meta-analyses that reports the efficacy of five treatments for children with attention-deficit hyperactivity disorder symptoms in the context of autism spectrum disorder - (a) methylphenidate; (b) atomoxetine; (c) guanfacine; (d) aripiprazole; and (e) risperidone. In this commentary, we highlight the contrast between the scarce evidence base of treatment for ADHD in the context of autism and other subpopulations, such as tic disorders and intellectual disability, and the extensive evidence base of treatment for ADHD in general. The commentary weighs about the conundrum clinicians face of whether to rely on the limited evidence base of treatment for ADHD in subpopulation, or to derive conclusions from the larger body of evidence of treatment for ADHD in general. The commentary also discusses potential avenues for future research to address this clinical problem.
Palavras-chave
Referências
- Bloch MH, 2009, J AM ACAD CHILD PSY, V48, P884, DOI 10.1097/CHI.0b013e3181b26e9f
- Cortese S, 2018, LANCET PSYCHIAT, V5, P727, DOI 10.1016/S2215-0366(18)30269-4
- Kent DM, 2020, ANN INTERN MED, V172, pW1, DOI 10.7326/M18-3668
- Mottron L, 2020, MOL PSYCHIATR, V25, P3178, DOI 10.1038/s41380-020-0748-y
- Reichow B, 2013, J AUTISM DEV DISORD, V43, P2435, DOI 10.1007/s10803-013-1793-z
- Rodrigues R, 2021, J CHILD PSYCHOL PSYC, V62, P680, DOI 10.1111/jcpp.13305
- Stigler KA, 2004, J CHILD ADOL PSYCHOP, V14, P49, DOI 10.1089/104454604773840481
- Sun CK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52205-6